CDC director defends unusual decision on Pfizer's Covid boosters: 'It was a scientific close call'
CDC Director Dr. Rochelle Walensky insisted Friday she didn't overrule a vaccine advisory committee by expanding the agency's approval of Pfizer's Covid boosters to include a proposal rejected by the panel.
In an unusual move, Walensky broke from the CDC's Advisory Committee on Immunization Practices, which voted9-6 Thursday against authorizing vaccines for those in high-risk transmission environments. Walensky adopted the panel's three other recommendations to distribute third shots to adults with underlying medical conditions and everyone 65 and older. She said the last vote, which clears extra doses for teachers, health workers and other essential employees, was a "scientific close call."
"I want to be very clear that I did not overrule an advisory committee," Walensky said at a White House Covid briefing Friday. "I listened to all of the proceedings of the FDA advisory committee and intently listened to this exceptional group of scientists that publicly and very transparently deliberated for hours over some of these very difficult questions and where the science was."
Walensky's directive aligns closely with the Food and Drug Administration's Wednesday ruling on boosters. That agency similarly bucked advice from its panel of scientific advisors by authorizing the shots for a broader audience than endorsed by its Vaccines and Related Biological Products Advisory Committee.
"This was a scientific close call," Walensky said, noting the lengthy two-day meeting and robust debate. With a split vote, Walensky said "it was my call to make. If I had been in the room I would have voted yes."
She sought to reassure public confidence by encouraging people to go back and listening to the committee's deliberations. "We did it publicly, we did a transparently and we did it with some of the best scientists in the country," she added.
President Joe Biden said the CDC's recommendation expanded boosters to approximately 60 million Americans – including educators, health-care personnel and supermarket employees – at a briefing Friday morning. The broader booster criteria better protects frontline workers and accounts for disparities in vaccine administration affecting people of color, Walensky said.
CNBC Health & Science
Read CNBC's latest global coverage of the Covid pandemic:
Vaccine mandates for travel are legal in the U.S. — and more are probably coming
FDA authorizes Pfizer's Covid booster shots for people 65 and older and other vulnerable Americans
Average daily U.S. Covid deaths climb above 2,000 for the first time since March
CDC says nursing home residents are still at risk for Covid with low vaccination rates among staff
"I'm also aware of the disproportionate impact this pandemic has had on racial and ethnic minority communities," Walensky said. "Many of our frontline workers, essential workers and those in congregate settings come from communities that have already been hardest hit."
She said withholding access to boosters for those groups will only worsen the inequities in the pandemic that have caused Black and Hispanic Covid patients to die at higher rates than whites.
More than 55% of the U.S. is fully vaccinated, and over 2.4 million people have received boosters since the agency authorized them for individuals with compromised immune systems on Aug. 13, according to the CDC.
Walensky said the agency would work to quickly assess the booster data from Moderna and Johnson & Johnson in the weeks ahead.
"We intend to have numerous advisory panels at the CDC to examine many upcoming decisions including Moderna, J&J, as well as pediatric vaccination," Walensky said.
Source: Read Full Article